Local News

Cornerstone BioPharma Adds Another Partner for Sale of Pain Drug

Posted June 8, 2006

— Cornerstone BioPharma

is adding another sales partner for its pain reliever Balacet 325.

Athlon Pharmaceuticals has signed on to utilize its sales force to promote Balacet 325. The drug, which is for treatment of mild to moderate pain, was approved by the Food and Drug Administration in 2005.

Cornerstone signed a co-promotion agreement with Ascend Therapeutics in March of this year.


Please with your WRAL.com account to comment on this story. You also will need a Facebook account to comment.

Oldest First
View all